Search
- May 3, 2023
- 4 min
Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials
We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum
- Apr 25, 2023
- 2 min
ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP
ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,
- Apr 19, 2023
- 2 min
Medical device company, BioVentrix closes on $48.5 million to improve cardiac function
BioVentrix is a medical device company focused on the development of less invasive therapies to treat the failing left ventricle.
- Apr 18, 2023
- 4 min
Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases
Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases
- Apr 14, 2023
- 4 min
Novo Holdings participates in $105 million funding in Alentis Therapeutics
Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.